Financial reports
10-Q
2023 Q3
Quarterly report
14 Nov 23
10-Q
2023 Q2
Quarterly report
14 Aug 23
10-Q
2023 Q1
Quarterly report
15 May 23
10-K
2022 FY
Annual report
31 Mar 23
10-Q
2022 Q3
Quarterly report
14 Nov 22
10-Q
2022 Q2
Quarterly report
15 Aug 22
10-Q
2022 Q1
Quarterly report
16 May 22
10-K
2021 FY
Annual report
24 Mar 22
10-Q
2021 Q3
Quarterly report
15 Nov 21
10-Q
2021 Q2
Quarterly report
13 Aug 21
Current reports
8-K
Bankruptcy or Receivership
4 Dec 23
8-K
Cost Associated with Exit or Disposal Activities
15 Nov 23
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
8 Nov 23
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
29 Sep 23
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
18 Aug 23
8-K
ContraFect Reports Second Quarter 2023 Financial Results and Provides Business Update
14 Aug 23
8-K
Other Events
25 Jul 23
8-K
Entry into a Material Definitive Agreement
27 Jun 23
8-K
Submission of Matters to a Vote of Security Holders
20 Jun 23
8-K
ContraFect Reports First Quarter 2023 Financial Results and Provides Business Update
15 May 23
Registration and prospectus
25-NSE
Exchange delisting
27 Dec 23
424B3
Prospectus supplement
3 Nov 23
S-1
IPO registration
30 Oct 23
S-1
IPO registration
24 Oct 23
S-3/A
Shelf registration (amended)
28 Apr 23
424B5
Prospectus supplement for primary offering
2 Mar 23
S-3
Shelf registration
9 Feb 23
424B5
Prospectus supplement for primary offering
14 Dec 22
S-8
Registration of securities for employees
23 May 22
S-8
Registration of securities for employees
23 May 22
Proxies
DEFA14A
Additional proxy soliciting materials
23 Oct 23
DEF 14A
Definitive proxy
25 Sep 23
PRE 14A
Preliminary proxy
14 Sep 23
DEFA14A
Additional proxy soliciting materials
18 May 23
DEF 14A
Definitive proxy
3 Apr 23
DEFA14A
Additional proxy soliciting materials
31 Jan 23
DEF 14A
Definitive proxy
3 Jan 23
PRE 14A
Preliminary proxy
22 Dec 22
DEF 14A
Definitive proxy
31 Mar 22
DEF 14A
Definitive proxy
6 Apr 21
Other
EFFECT
Notice of effectiveness
3 Nov 23
CORRESP
Correspondence with SEC
31 Oct 23
UPLOAD
Letter from SEC
30 Oct 23
EFFECT
Notice of effectiveness
4 May 23
CORRESP
Correspondence with SEC
1 May 23
UPLOAD
Letter from SEC
17 Feb 23
EFFECT
Notice of effectiveness
15 Dec 21
CORRESP
Correspondence with SEC
13 Dec 21
UPLOAD
Letter from SEC
13 Dec 21
EFFECT
Notice of effectiveness
1 Sep 20
Ownership
SC 13G/A
ARMISTICE CAPITAL, LLC
14 Feb 24
4
Michael Messinger
16 Feb 23
SC 13G
ARMISTICE CAPITAL, LLC
14 Feb 23
SC 13G/A
FEDERATED HERMES, INC.
9 Sep 22
SC 13G/A
BIOTECHNOLOGY VALUE FUND L P
19 Jul 22
4
Jane F Barlow
18 May 22
4
Cary Sucoff
18 May 22
4
MICHAEL J. OTTO
18 May 22
4
David N. Low
18 May 22
4
STEVEN C GILMAN
18 May 22